You are Invited to Attend

Liver Diseases Seen in Primary Care - Live Course

Saturday, October, 2018 – 8:00 A.M. to 4:30 P.M.


While nine of the 17 most common cancers of men and eight of the 18 most common cancers of women decreased in incidence in the U.S. (2009-2013), liver cancer had the greatest increase in incidence for both men and women (Annual Report to the Nation on the Status of Cancer, 1975 – 2014).  Death rates decreased for 11 of the top 16 cancers in men and for 13 of the top 18 cancers in women.  However, liver cancer death rates increased for men and women (Ibid).  This increase in liver cancer incidence and death rates can be attributed in large part to the most common liver diseases seen in primary care.


Your practice can have a profound effect on liver cancer incidence and death rates through readily available best practices.


At this course, you will learn about:


Hepatitis B (HBV)                                                                    Cirrhosis

Hepatitis C (HCV)                                                                    Liver Cancer (hepatocellular carcinoma)

Alcoholic hepatitis                                                                  Liver Transplantation

Non-Alcoholic Steatohepatitis (NASH)


All courses will be taught by Colorado specialists who are available for further consultation


Cost:  REDUCED to $20 to cover meals - includes breakfast and lunch with registration by May 12, 2018.  Register at: , click on the “Donate” button.


Held at University of Colorado Hospital, Anschutz Medical Campus, Aurora, CO


Contact:  Nancy Steinfurth, 720-917-3965, to register by phone or with questions about this program.


This Live activity, Liver Diseases Seen in Primary Care, with a beginning date of 05/19/2018, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Thank you to our supporters

World Hepatitis Alliance Member